论文部分内容阅读
Objective The aim of this study was to evaluate the one-month immune response to two different doses (10 and 20 μg) of recombinant hepatitis B vaccine in adults aged 25-46 years.Results Among 739 subjects, 62 (9.70%) were positive for HBsAg, and 317 subjects were eligible.